FDA reverses course on considering Moderna flu vaccine
February 19, 2026
5,860
147
2.51%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Amna Nawaz Episodes Around February 19, 2026
See what was published immediately before and after this episode.
0:59Now PlayingFDA reverses course on considering Moderna flu vaccine
YouTube Description
as posted by the channelThe Food and Drug Administration has reversed course and will now consider whether to approve a new flu shot from Moderna that uses mRNA technology.
The new development comes a week after the FDA rejected the company's initial application, saying its research design was flawed.
Moderna is now seeking full approval for the vaccine's use in adults aged 50 to 64 and what's called accelerated approval for those 65 and older.
The company says the FDA set an August deadline for approval. Moderna hopes to make the vaccine available later this year.
Sign up for Here's The Deal with Lisa Desjardins
Subscribe for exclusive content in our newsletters
PBS News podcasts
Stream your PBS favorites with the PBS app
Find more from PBS News at
Subscribe to our YouTube channel
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.